Related Experiment Video

Updated: Jul 11, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
04:44

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

Childhood systemic sclerosis

Francesco Zulian1, Giorgia Martini

  • 1Pediatric Rheumatology Unit, Department of Pediatrics, University of Padova, Italy. zulian@pediatria.unipd.it

Current Opinion in Rheumatology
|October 6, 2007
PubMed

Insights

Juvenile systemic sclerosis presents unique features in children, with better overall outcomes than in adults. New classification criteria aim for earlier diagnosis and improved care for this rare condition.

Area of Science:

  • Pediatric Rheumatology
  • Autoimmune Diseases
  • Scleroderma Research

Background:

  • Juvenile systemic sclerosis (jSSc) exhibits distinct clinical manifestations compared to adult-onset disease.
  • Early recognition and accurate classification are crucial for optimizing patient outcomes.

Purpose of the Study:

  • To summarize recent findings on the epidemiology and clinical features of childhood-onset systemic sclerosis.
  • To introduce new classification criteria for juvenile systemic sclerosis to enhance diagnosis and research standardization.

Main Methods:

  • A large multicenter study coordinated by the Pediatric Rheumatology European Society provided epidemiological and clinical data.
  • An ad-hoc Committee developed new classification criteria for juvenile systemic sclerosis.

Main Results:

  • The overall prognosis for children with systemic sclerosis is more favorable than in adults.
  • Rapid disease progression and early internal organ involvement are associated with a poor outcome in severe cases.
  • New classification criteria facilitate earlier and more definitive diagnoses.

Conclusions:

  • Juvenile systemic sclerosis has unique clinical characteristics and a generally better prognosis than adult systemic sclerosis.
  • New pediatric classification criteria have been proposed to improve diagnosis and research.
  • Evidence-based treatment recommendations for both adult and pediatric systemic sclerosis are under development.
Abstract

Related Concept Videos

Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
Autism Spectrum Disorder01:19

Autism Spectrum Disorder

Autism spectrum disorder (ASD) is a neurodevelopmental condition marked by persistent deficits in social communication and interaction alongside restrictive and repetitive behaviors or interests. ASD is sometimes accompanied by intellectual impairment.
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Satellite Stem Cells and Muscular Dystrophy01:21

Satellite Stem Cells and Muscular Dystrophy

Satellite stem cells or myosatellite cells are quiescent stem cells that Alexander Mauro first identified in 1961. These cells are located between the sarcolemma, the plasma membrane of muscle fibers, and the basal lamina, the connective tissue sheath covering it. These mononucleated cells are activated in response to muscle injury, can transform into myoblasts, and may form or repair muscle fibers. Myosatellite cells can provide additional myonuclei for muscle regeneration or return to a...